Two-sample survival tests based on control arm summary statistics

PLoS One. 2024 Jun 14;19(6):e0305434. doi: 10.1371/journal.pone.0305434. eCollection 2024.

Abstract

The one-sample log-rank test is the preferred method for analysing the outcome of single-arm survival trials. It compares the survival distribution of patients with a prefixed reference survival curve that usually represents the expected outcome under standard of care. However, classical one-sample log-rank tests assume that the reference curve is known, ignoring that it is frequently estimated from historical data and therefore susceptible to sampling error. Neglecting the variability of the reference curve can lead to an inflated type I error rate, as shown in a previous paper. Here, we propose a new survival test that allows to account for the sampling error of the reference curve without knowledge of the full underlying historical survival time data. Our new test allows to perform a valid historical comparison of patient survival times when only a historical survival curve rather than the full historic data is available. It thus applies in settings where the two-sample log-rank test is not applicable as method of choice due to non-availability of historic individual patient survival time data. We develop sample size calculation formulas, give an example application and study the performance of the new test in a simulation study.

MeSH terms

  • Computer Simulation*
  • Humans
  • Models, Statistical
  • Sample Size
  • Survival Analysis

Grants and funding

The work of MFD was funded by the German Science Foundation (Deutsche Forschungsgemeinschaft, DFG, https://www.dfg.de, grant number 413730122). The study was conducted within the framework of the GenderVasc project (Gender-specific real care situation of patients with arteriosclerotic cardiovascular diseases) funded by The Federal Joint Committee, Innovation Committee (G-BA, Innovationsfond, number 01VSF18051). GenderVasc is a cooperation project with the AOK Research Institute (WIdO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.